An Evaluation of the Safety and Preliminary Efficacy of Perioperative Treprostinil in Preventing Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients
Latest Information Update: 20 Nov 2023
Price :
$35 *
At a glance
- Drugs Treprostinil (Primary)
- Indications Ischaemia; Reperfusion injury
- Focus Adverse reactions; Pharmacokinetics
- 11 Nov 2023 Status changed from active, no longer recruiting to completed.
- 12 Jul 2023 Planned End Date changed from 1 Nov 2023 to 1 Nov 2024.
- 12 Jul 2023 Planned primary completion date changed from 1 Nov 2023 to 1 Nov 2024.